Revance Therapeutics Past Earnings image   This RVNC past earnings page last updated 5/1/2024
Revance Therapeutics Past Earnings
PeriodPast Earnings DateGAAP
Q4 20232/28/2024-0.620
Q3 202311/8/2023-0.550
Q2 20238/8/2023-0.800
Q1 20235/9/2023-0.740
Q4 20222/28/2023-1.820
Q3 202211/8/2022-1.170
Q2 20228/9/2022-0.880
Q1 20225/10/2022-0.940
Q4 20212/28/2022-0.930
Q3 202111/9/2021-1.100
Q2 20218/5/2021-1.070
Q1 20215/10/2021-1.080
Q4 20202/22/2021-1.240
Q3 202011/9/2020-1.340
Q2 20208/6/2020-1.120
Q1 20205/7/2020-1.150
Q4 20192/24/2020-0.990
Q3 201911/4/2019-0.960
Q2 20198/5/2019-0.860
Q1 20195/8/2019-0.850
Q4 20182/26/2019-1.12
Q3 201811/1/2018-0.91
Q2 20188/2/2018-0.94
Q1 20185/8/2018-0.97
Q4 20172/28/2018-1.04
Q3 201711/2/2017-1.01
Q2 20178/3/2017-0.9
Q1 20175/9/2017-0.94
Q4 20162/27/2017-0.95
Q3 201611/3/2016-0.64
Q2 20168/4/2016-0.88
Q1 20165/9/2016-0.71
Q4 20153/2/2016-0.83
Q3 201511/9/2015-0.81
Q2 20158/6/2015-0.71
Q1 20155/13/2015-0.65
Q4 20143/2/2015-0.6
Q3 201411/12/2014-0.72
Q2 20148/12/2014-0.69
Q1 20145/13/2014-1.93
Q4 20133/26/2014-47.11
Revance Therapeutics Past Revenue
PeriodPast Earnings DateGAAP
Q4 20232/28/20240.07B
Q3 202311/8/20230.06B
Q2 20238/8/20230.06B
Q1 20235/9/20230.05B
Q4 20222/28/20230.05B
Q3 202211/8/20220.03B
Q2 20228/9/20220.03B
Q1 20225/10/20220.03B
Q4 20212/28/20220.03B
Q3 202111/9/20210.02B
Q2 20218/5/20210.02B
Q1 20215/10/20210.01B
Q4 20202/22/20210.01B
Q3 202011/9/20200.00B
Q2 20208/6/20200.00B
Q1 20205/7/20200.06M
Q4 20192/24/20200.09M
Q3 201911/4/20190.05M
Q2 20198/5/2019NA
Q1 20195/8/20190.00B
Q4 20182/26/2019487000
Q3 201811/1/20182.36M
Q2 20188/2/2018686000
Q1 20185/8/2018193000
Q4 20172/28/201837000
Q3 201711/2/201775000
Q2 20178/3/201775000
Q1 20175/9/201775000
Q4 20162/27/201775000
Q3 201611/3/201675000
Q2 20168/4/201675000
Q1 20165/9/201675000
Q4 20153/2/201675000
Q3 201511/9/201575000
Q2 20158/6/201575000
Q1 20155/13/201575000
Q4 20143/2/201575000
Q3 201411/12/201480000
Q2 20148/12/201475000
Q1 20145/13/2014158000
Q4 20133/26/2014309000
Quotes delayed 20 minutes

Email EnvelopeFree RVNC Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Revance Therapeutics (RVNC) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

RVPH Past Earnings
RVTY Past Earnings
RXDX Past Earnings
RXRX Past Earnings
RXST Past Earnings
RYTM Past Earnings
RYZB Past Earnings
RZLT Past Earnings
SAGE Past Earnings
SANA Past Earnings

RVNC Past Earnings Q&A

What was the best and worst RVNC past earnings results?
For Revance Therapeutics, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest RVNC past earnings result in our data set was -0.550/share posted in Q3 2023, while the lowest was in Q4 2013 when RVNC posted -47.11/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q4 2023 when RVNC reported 0.07B in revenue, while the quarter with the lowest revenue in our data set was Q2 2019 at NA of revenue.

  Suggested answer: There are 41 RVNC past earnings results in our data set.

On this page we presented the RVNC past earnings date information for Revance Therapeutics. Reviewing that Revance Therapeutics Past Earnings for the company, we see that the highest past earnings result in our data set was in Q3 2023, when RVNC posted gaap of -0.550/share. Meanwhile the lowest RVNC past earnings result was in Q4 2013, when RVNC posted gaap of -47.11/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q4 2023 when RVNC reported 0.07B in revenue, while the smallest revenue quarter was Q2 2019 when RVNC reported NA in revenue.

Any self directed investor doing their due diligence on RVNC or any other given stock can benefit from researching all of the Revance Therapeutics past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Revance Therapeutics past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for RVNC. Thanks for visiting, and the next time you need to research RVNC past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: Institutional Holders of VSDA, Funds Holding ONLN, FNLC Videos.

 

Revance Therapeutics Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.